New Double Epigenetic Regimen in the Treatment of Relapsed or Refractory Acute Myeloid Leukemia | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
New Double Epigenetic Regimen in the Treatment of Relapsed or Refractory Acute Myeloid Leukemia	Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, hematologic disorder, leukemia, myeloid leukemia, neoplasm	Active, not recruiting	Phase 2	2026-03-19		NCT05029141

12 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Anhui Provincial Hospital	101
First Affiliated Hospital of Harbin Medical University	64
Fujian Medical University Union Hospital	108
Nanfang Hospital, Southern Medical University	248
Qilu Hospital of Shandong University	249
Ruijin Hospital	454
Shandong Provincial Hospital	112
The First Affiliated Hospital of Soochow University	164
The First Hospital of Jilin University	154
West China Hospital	359
Xinqiao Hospital of Chongqing	32
Zhengzhou University	21

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
The First Affliated Hospital of Soochow University	Suzhou	China	8